Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Inocras Inc.
Accent Therapeutics to Utilize Inocras’ CancerVision™ and MRDVision™ Platforms in Phase 1/2 ATX-295 Clinical Study
January 28, 2026
From
Inocras Inc.
Via
Business Wire
Inocras, Samsung Medical Center and Seoul St. Mary’s Hospital Researchers Publish Groundbreaking Study with 1,364 Whole-Genomes of Breast Cancer in Nature
December 03, 2025
From
Inocras Inc.
Via
Business Wire
Inocras Expands WGS-Based Cancer Precision Diagnostics CancerVision™ to 10 Hospitals
July 15, 2025
From
Inocras Inc.
Via
Business Wire
ChiMei Medical Center adopts Inocras MRDVision and WGS bioinformatics platform for precision oncology in Taiwan
July 07, 2025
From
Inocras Inc.
Via
Business Wire
Inocras and Center for Data Driven Discovery in Biomedicine Enter Collaborative Research Agreement to Advance Sinonasal Cancer Research
April 21, 2025
From
Inocras Inc.
Via
Business Wire
Inocras earns ISO 15189 accreditation from ANSI ASQ National Accreditation Board (ANAB)
December 10, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration Aim to Transform Clinical Genomics in Japan
November 05, 2024
From
Inocras Inc.
Via
Business Wire
Whole Genome MRD Detection with One-in-a-Million LOD: Inocras Launches WGS-Based, Panel-Free MRDVision, Leveraging Ultima ppmSeqTM Technology
October 31, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Unveils Breakthrough Study, Proving Target-Enhanced Whole-Genome Sequencing (TE-WGS) Outperforms Standard Panel Sequencing
October 09, 2024
From
Inocras Inc.
Via
Business Wire
Inocras to Offer High Quality and Cost-Effective Whole Genome Sequencing and Bioinformatics Services on Ultima UG 100TM platform
August 14, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching
June 03, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
May 31, 2024
From
Inocras Inc.
Via
Business Wire
Inocras and IMBdx Announce Strategic Partnership to Transform Cancer Patient Care in the U.S.
May 22, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Pioneers Precision Health with Revolutionary Whole Genome Insights
April 25, 2024
From
Inocras Inc.
Via
Business Wire
Inocras to Present Enhancing Genomic Analysis in Cancer Diagnostics at the 2024 AACR Annual Meeting
April 05, 2024
From
Inocras Inc.
Via
Business Wire
Inocras Inc. Unveils Rebranding of Genome Insight
March 18, 2024
From
Inocras Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today